Benzinga's Top Initiations By: Benzinga via Benzinga September 03, 2015 at 10:24 AM EDT Analysts at Citi initiated coverage on Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) with a Sell rating. Ultragenyx Pharmaceutical ... Read More >> Related Stocks: Capitala Finance Crp Ultragenyx Pharmaceu